Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples

NCT01744860

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Boulogne-Billancourt, France

Colmar, France

Lille, France

Lyon, France

View Trial Details

Completed

Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

NCT00973739

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +28 more
Locations: New York University School of Medicine New York, United States

View Trial Details

Completed

Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

NCT00026221

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: University of Cincinnati Cincinnati, Ohio, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients

NCT00936221

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Research Site Aurora, Colorado, United States

Research Site Boston, Massachusetts, United States

Research Site Belo Horizonte, Brazil

Research Site Ijuí, Brazil

View all 38 locations

View Trial Details

Completed

Phase 2 Study of Ipilimumab in Japanese Advanced Melanoma Patients

NCT01990859

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Local Institution Fukuoka, Japan

Local Institution Kumamoto, Japan

Local Institution Matsumoto-shi, Nagano, Japan

Local Institution Sunto-gun, Shizuoka, Japan

View Trial Details

Completed

Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children

NCT02129049

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +46 more
Locations: Bozeman Deaconess Hospital Bozeman, Montana, United States

Columbia Basin Hematology and Oncology PLLC Kennewick, Washington, United States

Tri-Cities Cancer Center Kennewick, Washington, United States

SCCA at EvergreenHealth Kirkland, Washington, United States

View Trial Details

Completed

Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma

NCT01665183

Conditions: Adnexal Diseases, Cutaneous Melanoma, Uveal Melanoma, Ovarian Carcinoma or Other Advanced Solid Tumors, Endocrine Gland Neoplasms, +28 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

NCKUH Tainan, Taiwan

View Trial Details

Completed

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

NCT00587964

Conditions: Bladder Cancer, Brain Diseases, Brain Metastasis, +73 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Phase I/IIa AdCD40L Immunogene Therapy for Malignant Melanoma and Other Solid Tumors

NCT01455259

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Uppsala University Hospital Uppsala, Sweden

View Trial Details

Completed

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery

NCT00738361

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +12 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions